IDEA Collider: Innovation & Asymmetric Learning in Pharma
IDEA Pharma, SAI MedPartners
Outreach Signals
Publishing Details
Contact & Outreach
About This Podcast
Social Media
Explore Statistics
Recent Episodes
S3E14 The Keytruda Blueprint: Alex Gray, David Radwaner, and Tom Brockbank on the IO Revolution
Welcome to IDEA Collider. In this episode, host Alex Gray is joined by IDEA Pharma colleagues David Radwaner and Tom Brockbank to dissect the history, strategy, and future of immuno-oncology (IO).…
S3E13 Scaling TCR-T Therapies: Reagan Jarvis on Non-Viral Gene Editing and Target Mapping
In this episode of the IDEA Collider, host Mike Rea sits down with Reagan Jarvis, scientific founder and CEO of Anocca, to explore how TCR-T cell therapy could unlock the next frontier in cancer…
S3E12 Vir Biotechnology: Marianne De Backer on Immuno-Oncology, Hepatitis Delta, and Biotech Turnarounds
In this episode of the IDEA Collider, host Mike Rea sits down with Marianne De Backer, CEO of Vir Biotechnology, to explore how she is leading one of biotech’s most complex transformations. After…
S3E11 Building the Future of Targeted Protein Degradation Medicines with Nello Mainolfi
In this episode of IDEA Collider, host Mike Rea sits down with Nello Mainolfi, founder and CEO of Kymera Therapeutics. Nello shares his journey from medicinal chemist to biotech founder and discusses…
S3E10 AI & Competitive Intelligence in Pharma: Smarter Decision-Making with SAI MedPartners
In this episode of the IDEA Collider podcast, industry experts explore the evolving role of AI in Competitive Intelligence (CI) in pharmaceutical and biotech strategy — and how organizations can move…
S3E9 Rewriting the Future of Rare Disease: Engineered tRNA and a New Therapeutic Paradigm with Michelle Werner
In this episode of IDEA Collider, host Mike Rea sits down with Michelle Werner, CEO of Alltrna, to explore a groundbreaking approach that could transform how we treat thousands of genetic…
S3E8 Revitalizing Pharma Collaborations: The Reblozyl Case Study
In this episode of IDEA Collider, hosts Mike and Rick revisit a pivotal project from over a decade ago, the Reblozyl project, undertaken in collaboration with Acceleron and Celgene. Rick, the head of…
S3E7 Pioneering the Future of Cardiovascular Treatment with Sekar Kathiresan
In this episode of IDEA Collider, host Mike Rea speaks with Dr. Sekar Kathiresan, founder of Verve Therapeutics and now part of Eli Lilly, about one of the boldest ideas in modern medicine: using…
S3E6 Biotech Innovations and AI in Drug Development with Alex Telford:
In this episode of IDEA Collider, we are joined by Alex Telford, a biotech founder, writer, and thinker based in the San Francisco Bay Area. As the co-founder of Convoke Bio, Alex discusses his…
S3E5 Dr. Christian Rommel on Oncology Innovations and Modern Drug Development at Bayer
In this episode of Idea Collider, host Mike Rea interviews Dr. Christian Rommel from Bayer. Dr. Rommel discusses his journey in molecular oncology from the Max Planck Institute, through roles at…
S3E4 Bold Science, Bigger Bets: Mathai Mammen on Visionary R&D and Transforming Biopharma
In this insightful episode of IDEA Collider, Mike welcomes Mathai Mammen, Chairman and CEO of Parabilis Medicines. Mathai shares his extensive journey through academia, MD PhD program at Harvard,…
S3E3 Bridging Clinical Practice and Biotech: Paul Peter Tak's Transformative Journey
In this episode of Idea Collider, host Mike Rea interviews Paul Peter Tak, CEO of Candel Therapeutics, discussing his remarkable journey from a clinician in Amsterdam to leading cutting-edge biotech…
S3E2 Creating Breakthroughs in Oncology: A Conversation with Susan Galbraith of AstraZeneca
In this episode of Idea Collider, we sit down with Susan Galbraith from AstraZeneca, a leading figure in oncology R&D. Susan shares her journey from medical training in Manchester and Cambridge…
S3E1 Biotech Innovations & Leadership with John Maraganore
In this episode of IDEA Collider, we dive into the world of biotech innovation with John Maraganore, former CEO of Alnylam Pharmaceuticals. Recognized as a trailblazer, John transformed RNA…
S2E16 IDEA Collider- with IDEA Pharma COO Jacqueline Barendregt and Exploristics Founder & CEO Aiden Flynn
We are excited to tell you more about the IDEA Pharma and Exploristics partnership. IDEA’s COO, Jacqui Barendregt, asked Exploristics Founder and CEO Aiden Flynn five key questions about the…
S2E15 Embracing Innovation and Collaboration in the Pharma Industry with Dr. Nedim Pipic
Welcome to another episode of Idea Collider with your host, Mike Rea. In this engaging conversation, we delve into the world of pharmaceutical innovation and collaboration. Our guest, Dr. Nedim…
S2E14 Exploring the book “Quit: The Power of Knowing When to Walk Away” by Annie Duke
Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today, Annie Duke joins us on the show to discuss her latest book, “Quit: The Power of…
S2E13 The Industrial Revolution of Drug Discovery with Dr. Michael Secora
Welcome to another incredible episode of the IDEA Collider series with your host Mike Rea. Today the Chief Financial Officer at Recursion, Dr. Michael Secora, joins us on the show as we discuss the…
S2E12 Embracing Digital Technology for Better Healthcare with Mary Lou Jepsen
The healthcare industry is moving towards a digital revolution. With the help of digital technology, healthcare providers can now provide better and more efficient services to their patients. Digital…
S2E11 Competitive Advantage & Positioning with Jaynie Smith
Welcome to another incredible episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today a competitive advantage expert, and CEO of Smart Advantage, Jaynie Smith, joins us on…
Frequently Asked Questions
IDEA Collider: Innovation & Asymmetric Learning in Pharma has published 68 episodes since September 2019, covering topics in Business, Life Sciences.
IDEA Collider: Innovation & Asymmetric Learning in Pharma is currently highly active with new episodes monthly. Average episode length is 48m.
Sign up on Grep.FM to access contact details for IDEA Collider: Innovation & Asymmetric Learning in Pharma, including email and social media links.
Similar Podcasts
Business Of Biotech
Ben Comer
310 episodes
Yoga Therapy Hour with Amy Wheeler
Amy Wheeler
247 episodes
Holdback Rack Podcast
Jessica Hare
241 episodes
The Business of Blueberries
U.S. Highbush Blueberry Council
200 episodes
THE EMBC NETWORK Featuring: ihealthradio and Worldwide Podcasts
Hurricane H
837 episodes
The Legal Field: Legal Perspectives in the Agriculture Industry
Amanda Carl
16 episodes